Loading…

Arteris, Inc.AIPCompetitor analysis, valuation and peers

United States · USD·Information Technology›Semiconductors

Licenses network-on-chip semiconductor IP that connects processor cores and components inside complex chip designs.

Momentum laggard 10
Mkt cap
$875M
US dollars, full cap
Free float
81%
of shares outstanding
$/day
$12.7M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
n/a
WACC 14.4%
Hurdle
+38 pp
Req g minus delivered
Next earnings
117 days
3 Mar 2027
Close · USD$17.80
1D+11.7%
1W-5.3%
1M-22.1%
3M-34.4%
6M-44.1%
YTD+14.8%
1Y+14.6%
ATR %8.5%
Beta3.35
52w lowhigh64.6% off high

What Arteris does

Licenses network-on-chip semiconductor IP that connects processor cores and components inside complex chip designs.

Charges a licence fee when a chip designer adopts its interconnect IP, then collects royalties on each chip shipped, so revenue builds from design wins that take years to turn into volume production. Automotive and consumer chips are major users.

Products and services

  • Network-on-chip (NoC) IP
  • FlexNoC/Ncore interconnect products

Customers

  • Chip designers building complex SoCs (automotive,

Where it sits in the supply chain

  • Information technology
  • Semiconductor IP
  • Network-on-chip (NoC) interconnect IP

What could go right

  • Growing SoC complexity driving interconnect IP demand

What could go wrong

  • Customer design-win concentration
  • Semiconductor design-cycle timing risk

Moat: narrow (IP / patents, switching costs). Interconnect IP is deeply embedded in customer chip designs, making it costly to switch mid-design.

Headquarters: Campbell, California, US · Founded: 2004 · Employees: 299

Named competitors

Arteris at a glance

Size Arteris (AIP) is a United States Information Technology company (Semiconductors) with a market value of $875M, the 2332nd largest of 3,117 United States companies the cockpit tracks. Shares closed at $17.80 on 6 Nov 2026.

Performance Over six months the shares fell 44.1%, against -13.8% for the median peer and -1.1% for the United States market (cap-weighted) — 2nd lowest of 21 in its peer set.

Growth Revenue grew 33.8% over the last twelve months (peer median -2.8%); the operating margin is -44.4% (peer median -1.5%).

Valuation It trades at 9.0× enterprise value to sales against a peer median of 4.5× (4th most expensive of 21).

Price implies For today's price to make sense, revenue must grow about 55% a year for seven years (Req g). Recent delivered growth is +17%, so the hurdle is +38 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Backlog Backlog (remaining performance obligations) was $131M at 30 Sep 2026, up 30% on a year earlier — 1.4 years of trailing revenue. Backlog detail →

Short interest Short interest is 5.7% of the free float (15 Oct 2026).

Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).

Relative performance

5010015011 May 202611 Aug 20266 Nov 2026Peer median 83AIP 54
Six months, rebased to 100: Arteris against the median of its 20 peers (local-currency closes).

Arteris financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$84.6M$70.6M$57.7M$53.7M$50.4M
Revenue growth—+22%+8%+7%—
Gross profit$71.6M$61.2M$49.2M$46.3M$44.5M
EBITDA-$33.0M-$29.8M-$28.2M-$32.1M-$26.8M
Net income-$39.5M-$34.7M-$33.6M-$36.9M-$27.4M
Free cash flow$6.77M$5.34M-$1.04M-$17.2M-$7.82M
Capital expenditure$1.74M$1.39M$324,000$1.50M$1.05M
Total debt$8.69M$5.97M$5.99M$7.75M$3.62M

Quarterly statements and history in the cockpit →

Arteris competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%-20%0%23883576300042301600299247728016603685496668851253516456AMBQ0028606883812393688601600207600770000541AIP6-month return →1-month return →
Up and to the right = strong over both horizons. Arteris is the large dot.

Fundamentals: revenue growth against valuation

-50%0%+50%+100%+150%0×5×10×238835763000423016002992477280166036854966688512535164566883812393688601600207600770AIPRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Arteris is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%+60%0%20%40%60%2388301647728016496653510028602393600770AIPGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Arteris is the large dot.

Arteris competitors and peer comparison

Head to head with its named competitors (AIP vs ARM vs SNPS vs CDNS)
CompanyMarket cap6M returnRevenue growthOp. marginEV / SalesReq g
Arteris AIP$875M-44%+34%-44%9.0×55.4%
Arm ARM$204B-18%+25%17%38.9×n/a
Synopsys SNPS$86.3B-13%+46%12%9.9×39.2%
Cadence Design Systems CDNS$87.8B-12%+18%30%14.5×29.9%
CEVA CEVA$763M-27%+9%-10%4.8×n/a

How Arteris compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Arteris against its 20 peers (data as of 6 Nov 2026)
MeasureAIPPeer medianRank in peer set
1-month return-22.1%-17.1%10th lowest of 21
6-month return-44.1%-13.8%2nd lowest of 21
Distance from 52-week high-64.6%-41.7%lowest of 21
Revenue growth (TTM)+33.8%-2.8%6th highest of 21
Operating margin-44.4%-1.5%3rd lowest of 21
EV / Sales9.0×4.5×4th most expensive of 21
Growth the price implies (Req g, 7 yrs)55.4%11.0%most demanding of 10
Growth delivered (Del g)+17.3%+4.7%3rd highest of 10
Hurdle (Req g minus delivered)+38.1 pp+1.3 pp3rd most demanding of 10

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Arteris AIPUnited States$875M-44%+34%-44%9.0×55.4%+17.3%
VIA Technologies 2388.TWTaiwan$874M-35%-3%-12%2.5×17.9%+8.0%
United Renewable Energy 3576.TWTaiwan$876M+15%-43%-62%12.2×n/an/a
Netac Technology 300042.SZChina$872M-44%+103%10%2.7×n/an/a
Episil-Precision 3016.TWTaiwan$865M-10%+30%14%5.8×40.5%-0.7%
Shenzhen Baoming Technology 002992.SZChina$887M-38%-20%-1%5.8×n/an/a
Taiwan Speciality Chemicals 4772.TWOTaiwan$862M-38%+164%40%7.8×11.0%+36.7%
Sitronix Technology 8016.TWTaiwan$894M+5%+18%13%1.0×-9.1%+6.6%
Zhejiang Chenfeng Science and Technology 603685.SSChina$896M-28%-14%4%6.9×n/an/a
Parade Technologies 4966.TWOTaiwan$915M-31%-3%14%1.9×3.8%+1.6%
Smarter Microelectronics (Guangzhou) 688512.SSChina$835M-11%+43%-30%5.0×n/an/a
Etron Technology 5351.TWOTaiwan$835M+13%+246%21%2.6×3.3%+2.6%
General Interface Solution (GIS) 6456.TWTaiwan$824M0%-19%-3%0.3×n/an/a
Ambiq Micro AMBQUnited States$933M-13%+32%-43%5.8×n/an/a
Hangzhou Star Shuaier Electric Appliance 002860.SZChina$810M+16%-14%7%2.5×19.8%+18.4%
Dioo Microcircuits Co., Ltd. Jiangsu 688381.SSChina$948M-15%-18%-46%11.1×n/an/a
Everlight Electronics 2393.TWTaiwan$807M-17%-3%10%0.8×-11.7%-1.9%
Wuxi ETEK Microelectronics 688601.SSChina$799M-25%+15%-5%5.7×n/an/a
Henan Ancai Hi-Tech 600207.SSChina$797M-13%-41%-39%4.0×n/an/a
Jiangsu Zongyi 600770.SSChina$961M-35%+64%-4%9.7×43.6%+4.7%
Foshan Electrical and Lighting 000541.SZChina$967M-8%-3%-2%1.1×n/an/a

Arteris backlog

Arteris reported $131M of remaining performance obligations at 30 Sep 2026, up 30% from a year earlier and down 0% from the previous quarter. That is 1.4 years of trailing revenue already under contract. Book-to-bill last quarter: 1.00.

Questions

Who are Arteris's main competitors?
Named competitors: Arm Holdings (ARM), Synopsys (SNPS), Cadence Design Systems (CDNS), CEVA (CEVA). The cockpit's measured peer set (industry) also includes VIA Technologies (2388.TW), United Renewable Energy (3576.TW), Netac Technology (300042.SZ), Episil-Precision (3016.TW), Shenzhen Baoming Technology (002992.SZ), Taiwan Speciality Chemicals (4772.TWO).
Is Arteris expensive compared with its peers?
On ev / sales it trades at 9.0× against a peer median of 4.5×, 4th most expensive of 21 in its peer set. For today's price to make sense, revenue must grow about 55% a year for seven years (Req g). Recent delivered growth is +17%, so the hurdle is +38 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Arteris stock performed?
Over six months to 6 Nov 2026 the shares returned -44.1% against -13.8% for the median peer; over one year +14.6%.
What is Arteris's backlog?
Arteris's remaining performance obligations (contracted revenue not yet recognised) were $131M at 30 Sep 2026, +30% on a year earlier.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.